Increasing Prevalence of Genetic Disorders to Stimulate the Global Microarray Analysis Market During the Forecast Period

Pune, India, September, 2022/press release/- Market Research Future Published a Half-Cooked Research Report on Microarray Analysis Market Research Report.

Market Synopsis

The global microarray analysis market is estimated to expand at a remarkable CAGR during the forecast period (2022-2030) owing to the increasing prevalence of genetic disorders, asserts Market Research Future (MRFR). Microarray analysis is a molecular biology technique which uses microchips with attached DNA segments used for gene expression analysis on a large scale. Microarray analysis is used in several experiments such as translation profiling, biomarker profiling, epigenetics, genotyping, pathway identification mutations, and gene expression profiling. It enables scientists analyze several genes at the same time with accurate results.

Drivers and Constraints Impacting the Market

With the growing focus on drug discovery and development, increasing prevalence of genetic disorders coupled with growing demand for personalized medicines, the global market is likely to trigger during the forecast period. Microarray analysis is used to understand gene patterns in tumors and also detect cancer biomarker. Thus, the growing prevalence of cancer along with rising investment for cancer research is estimated to fuel the market growth.

On the flip side, high cost associated with diagnosis, inaccurate results, and contamination is estimated to inhibit the market growth in the coming years.

Global Microarray Analysis Market: Segmental Analysis

The global microarray analysis market has been segmented on the basis of application, type, product type, end-user, and region.

By mode of type, the global microarray analysis market has been segmented into tissue microarrays, protein microarrays, glycan arrays, DNA microarrays, phenotype microarrays, chemical compound microarrays, and cellular microarrays. Among these, the segment for DNA microarrays is estimated to account for the largest market share owing to its extensive use in several applications such as diagnostic centers, pharmaceuticals, academic and research institutes, ambulatory care centers, hospitals and clinics, and biotechnology.

By mode of application, the market has been segmented into research, disease diagnosis, genomics, genotyping, proteomics, forensic analysis, drug discovery, and toxicological research. Among these, the drug discovery segment is predicted to expand at the highest CAGR during the assessment period.

By mode of product type, the global market has been segmented into DNA chips, reagents, primers, instruments, reagent kits, and buffers. Among these, the instrument segment has been sub-segmented into hybridization oven, Multi-Channel (MC) instrument, scanner, centrifuge, slide imprinters, target preparation instrument, and others.

By mode of end-users, the global market has been segmented into pharmaceuticals, academic and research institutes, biotechnology, diagnostic centers, hospitals and clinics, ambulatory care centers, and others.

Regional Insights

Geographically, the global market span across regions namely, Europe, America, Asia Pacific, and the Middle East and Africa.

Among all the regions, the American region is estimated to dominate the global market owing to the higher adoption rate of advanced technology for diagnosis, high investment in research and development, and rising awareness among the people for better diagnostics.

The European region is presumed to hold the second largest position in the global market owing to the increasing focus on personalized medicine, drug discovery, and targeted therapy.

The Asian Pacific market is estimated to register a substantial growth rate due to increasing prevalence of genetic disorders, government initiatives, and increasing awareness among the people. Meanwhile, the Middle East and Africa are estimated to hold the least share owing to the low funding in health and medical research.

Industry News

A team of researchers at Lund University, Herlev Hospital, Knight Cancer Center, and Immunovia AB, has developed a blood test that can detect pancreatic cancer at a very early stage. The blood test has been developed on an antibody microarray that comprises hundreds of recombinant antibody fragments.

Competitive Dashboard

The major players operating the global market are Discerna, Illumnia Inc., NextGen Sciences PLC, Roche NimbleGen, Thermo Fisher Scientific, Luminex Corporation, Agilent Technologies Inc., ProteoGenix, Biomerieux SA, Applied Microarrays, Gyros AB, Affymetrix Inc., Sequenom Inc., and others

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Microarray Analysis Market Research Report